Biogaran starts its operations in Mali! !

On February 21st, 2020, Biogaran organized an inaugural ceremony in the presence of 140 guests to announce the beginning of its commercial activities in Mali. This launch is part of a series of commercial developments in Côte d’Ivoire, Congo-Brazzaville and Gabon in 2019, as well as in Senegal in February 2020, and allows the laboratory to reinforce its commitment in favor of affordable quality medicines.

From left to right: Dr. Badra Aliou Wade (President of the Health Inter-Order of Mali), Mr. Sidy Diallo (Chief of Staff of the Minister of Health and Social Affairs), Prof. Hamar Alassane Traoré (Speaker), Mr. Valery Alves (Head of the Economic Service of the French Embassy in Mali), Dr. Cheickna Hamala Fofana (Sales Supervisor for Biogaran)

A wide range of medicines for the benefit of Malian patients

The inaugural launching ceremony took place on Friday 21st February at the Sheraton Hotel in Bamako in the presence of 140 guests, including Sidy Diallo, Chief of Staff of the Minister of Health and Social Affairs, Valery Alves, Head of the Economic Service of the French Embassy in Mali, Dr. Aliou Badra Wade, President of the Malian Health Inter-Order and Dr. Cheickna Hamala Fofana, Biogaran Sales Supervisor in Mali

In Mali, Biogaran is now providing patients with bioequivalent generic medicines from several therapeutic areas, covering common diseases such as hypertension, diabetes, bacterial infections and diarrhea. By providing patients in Mali with these bioequivalent generic medicines imported from France at an affordable price, Biogaran is helping to meet the challenges of access to medicines in Mali, which are considered a priority by the Malian government in its Ten-Year Health and Social Development Plan 2014-2023.

Supporting healthcare professionals and fighting against counterfeit medicines

The presence of Biogaran in Mali also aims at fighting against the spread of counterfeit drugs, which are very present in sub-Saharan Africa, where they are the cause of nearly 100,000 deaths each year, according to the WHO [1]. In this context, Biogaran is committed to providing patients and healthcare professionals in Mali with affordable and safe generic medicines, directly imported from France, where they treat millions of patients every day. Also, the tamper-proof packaging of Biogaran medicines guarantees that patients will take a quality medicine, manufactured in strict compliance with European standards.

“Access to quality medicines is an essential requirement in Mali. Our public authorities have understood the extent of the problem of fake medicines, a public health issue to which we are determined to respond in a firm, resolute and effective manner. In this task that we have set ourselves, the support of Biogaran is welcome and we will support them in their development on our territory, for the well-being of the patients of Mali,” said the Chief of Staff of the Minister of Health and Social Affairs, Sidy Diallo

The year 2019 was marked by the development of the activities of Biogaran in West and Central Africa, and more particularly in Côte d’Ivoire, Congo-Brazzaville and Gabon. This phase of expansion in Africa, initiated in 2019 and continued in 2020 with the deployment of its commercial activities in Senegal and then in Mali, demonstrates Biogaran’s desire to provide patients in sub-Saharan Africa with quality care at a fair price that they can use safely.

Biogaran in Mali

Present in Mali since February 2020, Biogaran wishes to contribute to national efforts regarding the access to quality medicines in Mali. In addition to its commercial activities, Biogaran has also worked to organize screening campaigns and free consultations to provide access to care for all.

You can consult the list of medicines available in Mali by clicking here.

[1] Sources – Nations Unies & Servier : https://www.un.org/africarenewal/magazine/may-2013/counterfeit-drugs-raise-africa%E2%80%99s-temperature

https://www.servier.ch/fr/actualites/news-detail/181/biogaran-reprend-les-activites-de-swipha-au-nigeria–afin-de-produire-des-medicaments-generiques-destines-au-marche-local/#_ftn1